Building Complex 3-Dimensional in Vitro Human Musculoskeletal and Skin Tissue Models (R43)

The summary for the Building Complex 3-Dimensional in Vitro Human Musculoskeletal and Skin Tissue Models (R43) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Building Complex 3-Dimensional in Vitro Human Musculoskeletal and Skin Tissue Models (R43): This Funding Opportunity Announcement (FOA) solicits Phase I R43 SBIR grant applications from small businesses to develop novel complex 3-dimensional (3-D) in vitro human musculoskeletal and skin tissue models that fit into the NIAMS mission (http://www.niams.nih.gov/About_Us/Mission_and_Purpose/mission.asp). These engineered 3-D human tissue or organ models would provide alternatives to animal models of diseases and animal testing, and enable the study of human tissue physiology and disease pathophysiology in vitro and ultimately lead to better therapies that prevent or cure diseases. Applicants may propose to engineer novel in vitro models and/or develop novel technologies to meet some of the specific challenges in building these models. All applications need to use human cells in the context of in vitro 3-D culture, and must be immediately relevant to NIAMS mission areas. This FOA is not intended to support research using non-human cells or animals. Non-responsive applications will not be reviewed
Federal Grant Title: Building Complex 3-Dimensional in Vitro Human Musculoskeletal and Skin Tissue Models (R43)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AR-17-005
Type of Funding: Grant
CFDA Numbers: 93.846
CFDA Descriptions: Arthritis, Musculoskeletal and Skin Diseases Research
Current Application Deadline: Oct 18, 2016
Original Application Deadline: Oct 18, 2016
Posted Date: Jan 19, 2016
Creation Date: Jan 19, 2016
Archive Date: Nov 18, 2016
Total Program Funding: $1,500,000
Maximum Federal Grant Award: $225,000
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-17-005.html
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 ...
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 ...
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...
Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)
Collaborative Arthritis and Musculoskeletal and Skin Diseases Science Award (Camssa)
Niams Small Grant Program for New Investigators
Skin Diseases Research Core Centers
More Grants from the National Institutes of Health
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...
Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com